Digirad Corporation Stock Price and Value Analysis

Should you buy Digirad Corporation stock? (NasdaqGM:DRAD). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company has a large dividend yield!
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is not making money.
  • This company is less known than others.

DRAD Free Cash Flow Trend

Hmm, we can't give any reliable projection for Digirad Corporation's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for Digirad Corporation

Inside the DRAD Numbers

DRAD Price
(Digirad Corporation stock price per share)
$0.73
[?] PE Ratio versus Sector 520% higher than other Healthcare stocks
[?] PE Ratio versus Industry 671% higher than other Medical Appliances & Equipment stocks
[?] Free Cash Flow Jitter 522%
[?] Dividend Yield 25%

Is Digirad Corporation Stock on Sale?

Based on our analysis, we believe that you should not buy Digirad Corporation right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy DRAD Stock?

Does Digirad Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.